Pain and I are well acquainted. I would not go so far as to say we are friends, but we do see each other every day. It isn’t always first thing in the morning; sometimes it’s midafternoon, right after I think to myself, “Wow, pain…
Bazedoxifene, a medication that alters the activity of the sex hormone estrogen, was safe and well-tolerated but did not promote myelin repair in women with multiple sclerosis (MS) in a Phase 2 clinical trial. The findings come from the ReWRAP study (NCT04002934) and were presented…
A Canadian study is challenging the growing belief that previous infection with the Epstein-Barr virus (EBV) is necessary for multiple sclerosis (MS) to develop. The findings suggest the virus may not precede every MS case. Using public health insurance claims data, the researchers found a…
La fortaleza y la autosuficiencia suelen considerarse como una medalla de honor. Para muchas personas, especialmente aquellas que viven con enfermedades crónicas o incertidumbre constante, la fortaleza se vuelve sinónimo de supervivencia. Nos permite superar días difíciles, pero a menudo … Continue reading → Source:…
Strength and self-reliance are often worn like a badge of honor. For many people, especially those living with chronic illness or ongoing uncertainty, strength becomes synonymous with survival. It allows us to push through difficult days, but it often comes … Continue reading → Source:…
Tweet Loss of circulating antibody as a result of continuous B cell depletion is a risk factor for infection. The battle grounds to distinguish between the different anti-CD20 has been centred on loss of IgG. It has been suggested that ofatumumab does not induce as…
The post Auto Draft appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
Better adherence to a Mediterranean-like diet may help prevent disability worsening in people with early multiple sclerosis (MS), in part by slowing biological aging, according to data from a new study. The findings suggest that diet, biological age, and disability are closely connected and that…
The investigational BTK inhibitor tolebrutinib did not lower the risk of confirmed disability progression compared with placebo in people with primary progressive multiple sclerosis (PPMS), failing to meet the main goal and several key secondary goals of the Phase 3 PERSEUS trial. It did, however,…
Tweet A couple of years ago we were awakened to the prospect of EBV being the cause of multiple sclerosis, at least part of the causal route. It was based on two papers one that it was shown that people who develop MS were infected…